RRBC Capital AASML · ASML

RBC Capital Increases ASML Price Target to $2,100

Jul 16, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$2,000
Previous
$2,000
Implied upside
+10%

RBC Capital analyst Srini Pajjuri raised the price target on ASML Inc.

(NASDAQ: ASML) to $2,100 (from $2,000) while maintaining an Outperform rating.

“Unit demand strong; ASML’s results and outlook were above our recent expectations.

Management now sees ~65/85 low-NA units for 2026/27 vs at least 60/80 previously, and is investigating another 30% capacity expansion for 2028.

While the 2027 number may have fallen short of more bullish investor expectation for 90 units, we believe there is still room for upside.

In addition, mix is set to improve next year and management also sees “more flexibility” in (like-for-like) pricing.

Services continues to fare well and Immersion demand is tracking ahead, both tailwinds to gross margins.

We are raising estimates and expect revenue & margin momentum to sustain through 2028, and see room for further upside from potential pricing actions.

We raise PT from $2,000 to $2,100 and reiterate Outperform.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.